Mylenda 0.5 mg/0.5 ml SC injection contains Semaglutide 0.5 mg/0.5 ml. It is a glucagon-like peptide-1 (GLP-1) receptor agonist medicine used to improve blood glucose control in adults with type 2 diabetes mellitus and to support weight management in appropriate patients.
Uses:
Treatment of type 2 diabetes mellitus.
Helps reduce high blood glucose levels.
Used along with diet and exercise to improve glycemic control.
Helps reduce the risk of cardiovascular complications in certain patients with type 2 diabetes and cardiovascular risk factors.
Supports weight management in suitable patients.
Dose:
Adults: Usually 0.5 mg once weekly by subcutaneous injection, after initial dose escalation as directed by a physician.
Inject under the skin of the abdomen, thigh, or upper arm as instructed by a healthcare professional.
Dose and duration depend on the patient's medical condition, blood glucose levels, and response to treatment.
Use the medicine exactly as prescribed by a healthcare professional.